Cargando…

Alternative splicing events are prognostic in hepatocellular carcinoma

Alternative splicing events (ASEs) play a role in cancer development and progression. We investigated whether ASEs are prognostic for overall survival (OS) in hepatocellular carcinoma (HCC). RNA sequencing data was obtained for 343 patients included in The Cancer Genome Atlas. Matched splicing event...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qi-Feng, Li, Wang, Wu, Peihong, Shen, Lujun, Huang, Zi-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660027/ https://www.ncbi.nlm.nih.gov/pubmed/31301224 http://dx.doi.org/10.18632/aging.102085

Ejemplares similares

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma
por: Zhang, Yong-Fa, et al.
Publicado: (2021)

Profiles of m(6)A RNA methylation regulators for the prognosis of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma
por: Yu, Shanshan, et al.
Publicado: (2021)

Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancer tissues
por: Wu, Min, et al.
Publicado: (2017)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
por: Xiong, Yongfu, et al.
Publicado: (2020)

Prognostic significance of survival-associated alternative splicing events in gastric cancer
por: Zhang, Shichao, et al.
Publicado: (2020)

ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β-catenin signaling pathway
por: Chen, Qi-Feng, et al.
Publicado: (2020)

Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Alternative Splicing in Hepatocellular Carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2020)

Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data
por: Shen, Lujun, et al.
Publicado: (2018)

Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data
por: Xu, Ning, et al.
Publicado: (2020)

Prognostic role of alternative splicing events in head and neck squamous cell carcinoma
por: Ding, Yanni, et al.
Publicado: (2020)

Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma
por: Liu, Zhao-chen, et al.
Publicado: (2022)

Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment
por: Li, Zhi-Xuan, et al.
Publicado: (2019)

A Prognostic Nomogram Incorporating Depth of Tumor Invasion to Predict Long-term Overall Survival for Tongue Squamous Cell Carcinoma With R0 Resection
por: Chang, Boyang, et al.
Publicado: (2018)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer
por: Huang, Xiaoliang, et al.
Publicado: (2019)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis
por: Lin, Peng, et al.
Publicado: (2019)

Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
por: Jia, Keren, et al.
Publicado: (2019)

Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer
por: Liu, Jingwei, et al.
Publicado: (2018)

Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma
por: Zhang, Jian, et al.
Publicado: (2016)

Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer
por: Wei, Chunyin, et al.
Publicado: (2021)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Comprehensive analysis of prognosis-related alternative splicing events in ovarian cancer
por: Wang, Shizhi, et al.
Publicado: (2022)

High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients
por: Chang, Boyang, et al.
Publicado: (2018)

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma
por: Jiang, Yue, et al.
Publicado: (2022)

Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma
por: Wan, Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bv372hsk36bf43vof7hfb5kn60